Technical Analysis for XAIR - Beyond Air, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | -5.43% | |
| Doji - Bearish? | Reversal | -5.43% | |
| Wide Bands | Range Expansion | -5.43% | |
| Crossed Above 20 DMA | Bullish | -5.43% | |
| Inside Day | Range Contraction | -5.43% | |
| Wide Bands | Range Expansion | -5.43% | |
| Fell Below 20 DMA | Bearish | -2.79% | |
| Wide Bands | Range Expansion | -2.79% | |
| Crossed Above 20 DMA | Bullish | -6.15% | |
| MACD Bullish Signal Line Cross | Bullish | -6.15% |
| Alert | Time |
|---|---|
| Down 5% | about 2 hours ago |
| Fell Below 20 DMA | about 2 hours ago |
| 60 Minute Opening Range Breakdown | about 2 hours ago |
| 20 DMA Support | about 3 hours ago |
| Fell Below Previous Day's Low | about 3 hours ago |
Get a Trading Sidekick!
- Earnings date: 06/20/2024
Beyond Air, Inc. Description
Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The Beyond Air NO Delivery System can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. The Company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections such as nontuberculous mycobacteria (NTM).
Classification
Sector: Industrials
Industry: Conglomerates
Keywords: Medicine Biopharmaceutical Hypertension Coronavirus Bacterial Disease Pulmonary Hypertension Tuberculosis Bacteriology Lung Infection Nontuberculous Mycobacteria Lower Respiratory Tract Infection Lung Infections Mycobacterium Respiratory And Other Diseases Respiratory Tract Respiratory Tract Infection
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.36 |
| 52 Week Low | 1.06 |
| Average Volume | 281,340 |
| 200-Day Moving Average | 2.06 |
| 50-Day Moving Average | 1.51 |
| 20-Day Moving Average | 1.25 |
| 10-Day Moving Average | 1.20 |
| Average True Range | 0.14 |
| RSI (14) | 46.81 |
| ADX | 11.34 |
| +DI | 23.94 |
| -DI | 16.40 |
| Chandelier Exit (Long, 3 ATRs) | 1.27 |
| Chandelier Exit (Short, 3 ATRs) | 1.48 |
| Upper Bollinger Bands | 1.45 |
| Lower Bollinger Band | 1.04 |
| Percent B (%b) | 0.6 |
| BandWidth | 32.98 |
| MACD Line | -0.08 |
| MACD Signal Line | -0.10 |
| MACD Histogram | 0.0272 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.52 | ||||
| Resistance 3 (R3) | 1.52 | 1.46 | 1.48 | ||
| Resistance 2 (R2) | 1.46 | 1.40 | 1.45 | 1.46 | |
| Resistance 1 (R1) | 1.37 | 1.36 | 1.37 | 1.37 | 1.45 |
| Pivot Point | 1.31 | 1.31 | 1.30 | 1.30 | 1.31 |
| Support 1 (S1) | 1.22 | 1.25 | 1.22 | 1.22 | 1.13 |
| Support 2 (S2) | 1.16 | 1.21 | 1.15 | 1.12 | |
| Support 3 (S3) | 1.07 | 1.16 | 1.10 | ||
| Support 4 (S4) | 1.07 |
